e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Clinical aspects of idiopathic pulmonary fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Idiopathic pulmonary fibrosis: independent physiologic variables in the prediction of survival
M. Mura, P. Rogliani, M. A. Porretta, P. Contini, M. Amicosante, M. Schiavina, C. Saltini (Rome, Bologna, Italy)
Source:
Annual Congress 2007 - Clinical aspects of idiopathic pulmonary fibrosis
Session:
Clinical aspects of idiopathic pulmonary fibrosis
Session type:
Thematic Poster Session
Number:
3432
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Mura, P. Rogliani, M. A. Porretta, P. Contini, M. Amicosante, M. Schiavina, C. Saltini (Rome, Bologna, Italy). Idiopathic pulmonary fibrosis: independent physiologic variables in the prediction of survival. Eur Respir J 2007; 30: Suppl. 51, 3432
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema
Source: Eur Respir J 2011; 37: 176-183
Year: 2011
The six minute walking test: Clinical predictors of survival in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity
Year: 2013
Idiopathic pulmonary fibrosis: Gender differences in survival and functional decline. A retrospective study
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Comparison of clinical characteristics and prognostic factors between combined pulmonary fibrosis and emphysema/UIP versus non-UIP
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis
Source: Eur Respir J 2010; 36: 1067-1072
Year: 2010
Genetic predictors of idiopathic pulmonary fibrosis (IPF) prognosis
Source: Eur Respir J 2006; 28: Suppl. 50, 830s
Year: 2006
Pulmonary hypertension as a predictor of survival in cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 230s
Year: 2003
Idiopathic pulmonary fibrosis: Relationship between patient survival and distance-saturation product
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 25: 96-103
Year: 2005
Predictor factors of mortality in patients with idiopathic pulmonary fibrosis
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018
Risk prediction and end-points in idiopathic pulmonary fibrosis: one step at a time
Source: Eur Respir J 2014; 43: 1237-1239
Year: 2014
Idiopathic pulmonary fibrosis: does smoking status influence outcome?
Source: Eur Respir J 2006; 28: Suppl. 50, 830s
Year: 2006
Dyspnoea: a prognostic marker for idiopathic pulmonary fibrosis
Source: Eur Respir J 2011; 37: 476
Year: 2011
Clinical course of idiopathic pulmonary fibrosis (IPF): Prediction and outcome
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011
Cluster analysis and survival in patients with Idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020
Idiopathic pulmonary fibrosis: Clinical, radiological and functional significance of biomarkers of proliferation
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012
Different definitions of pulmonary hypertension in interstitial lung disease: a prognostic evaluation.
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020
Pulmonary hypertension in idiopathic pulmonary fibrosis: correlation to pulmonary function and exercise parameters
Source: Eur Respir J 2007; 30: Suppl. 51, 607s
Year: 2007
Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis
Source: Eur Respir J, 50 (1) 1700379; 10.1183/13993003.00379-2017
Year: 2017
Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome
Source: Eur Respir J 2011; 37: 356
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept